The role of CMV infection in persistent immune activation and its contribution to poorer health have been extensively studied among HIV+ and HIV-uninfected populations [23,41,50,51], and the effect of CMV infection has been demonstrated by the significant reduction of activated CD8+ T-cells in blood after valganciclovir therapy [50]. Here, CD8A is linked to cytomegalovirus infection.